|
501 Now
is the time to be proactive, pharmacists told With primary
care trusts being reorganised, now is the time for pharmacists to be
proactive in developing, and showing leadership in, primary care services
at a local level, Michael Dixon, chairman of the NHS Alliance, told a
meeting of the All-Party Pharmacy Group this week ...more
501 Clinical
leadership essential in reconfigured PCTs, says Secretary of State for
Health Strong and continuing leadership from all clinical
professionals is essential in reconfigured primary care trusts ...more
501 Agenda for
Change almost fully implemented in the NHS Most NHS staff
in England have now been moved to Agenda for Change pay scales and terms
and conditions ...more
501 Specialised
services review The provision of specialised services in the
NHS in England is to be reviewed by a Department of Health task force
...more
502 Updated flu
pandemic contingency plan launched Pharmacists, as well as
GPs, might provide antiviral drugs in the event of an influenza pandemic,
Chief Medical Officer Sir Liam Donaldson said at the launch of the revised
UK influenza contingency plans this week ...more
502 Partially
resistant avian flu virus isolated An H5N1 strain of avian
influenza virus that is partially resistant to oseltamivir (Tamiflu)
has been isolated from a Vietnamese patient, according to a brief communication
published in Nature ...more
502 Medical charity
appeals to pharmacists to donate supplies of medicines and equipment
for Asian Earthquake Medical charity appeals to pharmacists
to donate supplies of medicines and equipment for Asian Earthquake ...more
502 Lloydspharmacy
grows Lloydspharmacy is to gain a further 111 pharmacies
...more
502 Stop smoking
campaign Local smoking cessation services are being highlighted
in a campaign launched by the Scottish Executive ...more
503 CD regulation
changes post-Shipman should apply to all health care professionals, says
Society Any changes to the regulations for Controlled Drugs following the Shipman Inquiry should apply to all health professionals in both the NHS and the private sector, the Royal Pharmaceutical Society said this week
...more
503 Co-op group
pharmacies linked up to NPSA reporting system All 360 UK pharmacies
within Co-operative Group Pharmacy can now send details of any safety
incidents, such as dispensing errors, via a web-based system developed
by the company direct to the National Reporting and Learning System at
the National Patient Safety Agency ...more
503 No new safety concerns for non-selective NSAIDs There are no new safety concerns related to cardiovascular and gastrointestinal safety and serious skin reactions with non-selective non-steroidal anti-inflammatory drugs (NSAIDs), the European Medicines Agency (EMEA) has concluded. However, the agency has identified key elements that it says should be included in all product information for non-selective NSAIDs
...more
503 Angiotensin
receptor blockers Researchers report that candesartan is associated
with a reduced risk of nonfatal myocardial infarction in patients with
heart failure. However, a broader systematic review of 19 studies has
revealed a neutral association, with neither an increased nor decreased
risk for angiotensin receptor blocker use ...more
503 Claw back
cut Claw back is to be reduced in Scotland from 9.9 to 9.1
per cent, with effect from September 2005 dispensings ...more
503 Patient-held
records Gypsies and travellers in Scotland are to be given
a patient-held medical record booklet ...more
503 Prescription
charge inquiry The Health Select Committee has announced an
inquiry into NHS charges, including prescription charges ...more
|
504 Infliximab
licensed for psoriasis Infliximab (Remicade) has been licensed
for the treatment of psoriasis ...more
504 Beta-blockers
should not be first-line for BP Treatment with beta-blockers
is about half as effective at preventing strokes as previous trials have
suggested and is less effective than treatment with other, similarly
priced, antihypertensive drugs, a meta-analysis published online on 18
October suggests ...more
504 Lack of evidence
for excessive sweating treatments There is a lack of published
evidence to support treatments for excessive sweating, according to the
latest issue of the Drug and Therapeutics Bulletin ...more
505 Most US guideline
panels have conflicts of interests One in three academics
and doctors who write clinical practice guidelines have a financial interest
in the drug company associated with the drugs they recommend, according
to the results of a US survey published this week ...more
505 Pfizer “broke
competition rules” Pfizer has been accused of breaking
European competition rules by introducing a pricing structure in Spain
that makes exporting to other European countries uneconomic ...more
505 NPA concerned
about fluconazole P-to-GSL reclassification The National Pharmacy
Association has expressed concern about the Medicines and Healthcare
products Regulatory Agency's proposal to reclassify fluconazole 150mg
capsules from a pharmacy-only to a general sale list medicine. And Bayer,
manufacturer of Canesten Oral (fluconazole), has warned that the reclassification
may pose a risk to pregnant women ...more
506 Complementary
therapy costly and of limited benefit Complementary treatments
represent an additional cost to usual care in the UK and have questionable
clinical benefit, a review in the BMJ argues ...more
506 NICE clarifies
guidance on use of clopidogrel The National Institute for
Health and Clinical Excellence has clarified its guidance on the use
of clopidogrel in acute coronary syndromes (ACS) ...more
506 Docetaxel
accepted by SMC for use within NHS Scotland Docetaxel (Taxotere)
has been accepted for use as a breast cancer treatment within NHS Scotland,
the Scottish Medicines Consortium announced last week ...more
506 Pharmacy
team wins national NHS Innovations award Pharmacists at Guildford
and Waverley Primary Care Trust have won this year's annual NHS Innovation
award for innovative service technology ...more
|
The
Pharmaceutical Journal